Status:
COMPLETED
Hypertension and Cardiovascular Risk Factors
Lead Sponsor:
Novartis
Conditions:
HYPERTENSION
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
A study to evaluate the efficacy of valsartan+chydochlorothiazide in patients with stage 2 hypertension and cardiovascular risk factors.
Eligibility Criteria
Inclusion
- \- Patients who give consent
- Men and women 18 to 80 years of age
- Patients with hypertension (systolic \>159 mm, diastolic \>100 mm)
- Patients meeting laboratory criteria
Exclusion
- \- Pregnant women
- Women not using approved contraception methods
- Secondary hypertension
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2004
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT00171782
Start Date
February 1 2004
End Date
December 1 2004
Last Update
October 12 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.